Aarti Drugs considers formulations driven plant acqusition

By Gareth Macdonald contact

- Last updated on GMT

Related tags: Pharmacology

Aarti Drugs considers formulations driven plant acqusition
Aarti Drugs has said it is considering buying an unnamed manufacturer in Himachal Pradesh, India to expand its drug formulations business

The Mumbai-based drugmaker told the BSE about the potential takeover earlier today​. The firm explained that it “has considered a proposal to acquire an undertaking/Company at Baddi in Himachal Pradesh to cater its existing business of Toll [contract] manufacturing of formulations as an initiative to have its own facilities for this business subject to necessary diligences and approval processes​.”

Aarti operates two production facilities - in Tarapur, Maharashtra and Sarigam, Gujarat – at which it produces more than 50 bulk active pharmaceutical ingredients (API), several pharmaceutical intermediates and a range of speciality chemicals.

Details of the potential acquisition target were not provided.

Related news

Show more

Related product

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Follow us

Products

View more

Webinars